Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন*
Indications:
DECOMIT HFA 100 is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients requiring inhaled corticosteroids.
Pharmacology:
DECOMIT HFA 100 contains Budesonide, a glucocorticoid steroid with potent anti-inflammatory properties. It works locally in the lungs to reduce inflammation and prevent asthma symptoms.
Dosage:
Adults and adolescents (12 years and older): 1-2 inhalations twice daily or as directed by a physician.
Children (6-11 years): Dose should be determined by a physician.
Administration:
The inhaler should be shaken well before use. Patients should exhale fully, place the mouthpiece into the mouth, and inhale deeply while pressing the canister.
Interaction:
Budesonide may interact with CYP3A4 inhibitors like ketoconazole, ritonavir, or clarithromycin, which can increase its systemic exposure.
Contraindications:
Contraindicated in patients with a history of hypersensitivity to budesonide or any component of the formulation.
Side Effects:
Common side effects include hoarseness, throat irritation, and oral candidiasis. Rinsing the mouth after use reduces the risk of infection.
Pregnancy & Lactation:
Should be used during pregnancy only if clearly needed. Budesonide may pass into breast milk, but considered safe when inhaled. Consult a doctor before use.
Precautions & Warnings:
Not intended for relief of acute asthma attacks. Use with caution in patients with active or quiescent tuberculosis infections, fungal, bacterial, or viral infections of the respiratory tract.
Therapeutic Class:
Inhaled corticosteroids
Storage Conditions:
Store below 30°C. Protect from light and moisture. Keep out of reach of children.
 100 IU.jpg)
 30PCS.jpg)
 400MG.jpg)
 350ML.jpg)
 10025 100 MG 25 MG.jpg)
.jpg)
 100 IU.jpg)
 20025 20025.jpg)
 60 ML.jpg)
 350ML.jpg)
.jpg)
 15050160.jpg)
Change Language